Abstract:Hypertension, Ahead of Print. BACKGROUND:Renin-independent aldosterone production in normotensive people increases risk for developing hypertension. In parallel, normotensive adrenal glands frequently harbor aldosterone-producing micronodules with pathogenic somatic mutations known to induce primary aldosteronism (PA). A deeper understanding of these phenomena would inform the origins of PA and its role in hypertension pathogenesis.METHODS:Prospectively recruited normotensives underwent detailed characterization of PA features via the following: oral sodium suppression test to evaluate renin-independent aldosterone production, dexamethasone suppression and adrenocorticotropic hormone-stimulation tests to evaluate adrenocorticotropic hormone-mediated aldosterone production, and 24-hour ambulatory blood pressure monitoring. The magnitude of renin-independent aldosterone production was defined via using tertiles of 24-hour urinary aldosterone production during the oral sodium suppression test to create unbiased categorizations of the magnitude of PA. Serum aldosterone, serum 18-hybrid steroids, urine tetrahydroaldosterone (biomarkers of aldosterone synthase activity), urinary potassium, and blood pressure (biomarkers of mineralocorticoid receptor activation) were evaluated across tertiles.RESULTS:There was a spectrum of autonomous, nonsuppressible, and renin-independent production of aldosterone, 18-hybrid steroids, and 24-hour urinary tetrahydroaldosterone (P-trend <0.01). Correspondingly, there was a continuum of adrenocorticotropic hormone-mediated aldosterone production and 18-hybrid steroid production that also paralleled renin-independent aldosterone production. The spectrum of PA pathophysiology was associated with higher ambulatory daytime systolic BP (P-trend <0.05), even within the normotensive range, and greater urinary potassium excretion (P-trend <0.05), indicating a continuum of mineralocorticoid receptor activation.CONCLUSIONS:The pathophysiologic continuum of PA, characterized by renin-independent and adrenocorticotropic hormone-mediated aldosterone production, and enhanced aldosterone synthase and mineralocorticoid receptor activity, is evident in normotensive people. These findings provide mechanistic explanations to implicate PA in the pathogenesis of a substantial proportion of hypertension.

Regulation of Aldosterone Production by Ion Channels: from Basal Secretion to Primary Aldosteronism

Role of Voltage‐gated Calcium Channels in the Regulation of Aldosterone Production from Zona Glomerulosa Cells of the Adrenal Cortex

Minireview: Aldosterone Biosynthesis: Electrically Gated for Our Protection

L- and T-type Calcium Channels Control Aldosterone Production from Human Adrenals

Modulation of calcium signaling on demand to decipher the molecular mechanisms of primary aldosteronism

Small-Conductance Ca2+-Activated Potassium Channels Negatively Regulate Aldosterone Secretion in Human Adrenocortical Cells.

Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome

Pathogenesis and treatment of primary aldosteronism

Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas

Evaluating the role of aldosterone synthesis on adrenal cell fate

What We Know about and What Is New in Primary Aldosteronism

Evolutionary Characteristics in Primary Aldosteronism Patients

Characterizing the Origins of Primary Aldosteronism

Proteomic Landscape of Aldosterone-Producing Adenoma

Zona Glomerulosa Cells of the Mouse Adrenal Cortex Are Intrinsic Electrical Oscillators.

A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism

Latest findings in molecular pathogenesis of primary aldsosteronism

Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension

Research progress of molecular mechanism in primary hyperaldosteronism

Transcriptome Analysis of Primary Aldosteronism in Adrenal Glands and Controls.